This article is more than 5 years old. Information may no longer be current.

VIDEO: Radioactive iodine often not needed in low-risk thyroid cancer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BOSTON — In this video exclusive, Megan R. Haymart, MD, assistant professor of metabolism, endocrinology and diabetes from the University of Michigan, in Ann Arbor, discusses her presentation on the use of radioactive iodine in the treatment of low-risk thyroid cancer.

According to Haymart, the main point of the guidelines for radioactive iodine on whether to treat or not to treat low-risk thyroid cancer is that patients with low-risk disease do not routinely need radioactive iodine. She adds that this is a weak recommendation with low-quality evidence.

Haymart said that the guidelines are very thorough and were successful in using evidence available to date.